What stands out
- Pays more per share than it earned over the last twelve months
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleRevenue is $31.17M, lower than 95% of all stocks globally
- FinancialsAltman Z-Score 11.52: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
What stands out
- Pays more per share than it earned over the last twelve months
Dividends view
Yield
0.50%Below 5Y avg (0.62%)
Annual Rate
CNY 0.14Paid annual
Payout Ratio
186.6%High
Last Ex-Dividend
Jun 1, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.20BCNY330.21M · vs all stocks (USD)
Trailing P/E
342.50xRevenue (TTM)
207.96MCNY31.17M · vs all stocks (USD)
Profit Margin
2.83%Beta
0.5200xvs all stocks
52-Week Change
-8.16%vs all stocks
Market Capitalization
2.20BCNY330.21M · vs all stocks (USD)
Enterprise Value
1.91BCNY286.91M · vs all stocks (USD)
Trailing P/E
342.50xPrice to Sales (TTM)
10.08xPrice to Book (MRQ)
2.37xEnterprise to Revenue
9.21xEnterprise to EBITDA
51.60xGross Margin
75.53%Profit Margin
2.83%Operating Margin
-8.97%Return on Assets (TTM)
-0.23%Return on Equity (TTM)
0.46%Revenue (TTM)
207.96MCNY31.17M · vs all stocks (USD)
Revenue per Share (TTM)
2.73CNYUpdated Oct 21, 2026Quarterly Revenue Growth
-40.20%Gross Profit (TTM)
152.70MCNY22.89M · vs all stocks (USD)
EBITDA (TTM)
56.78MCNY8.51M · vs all stocks (USD)
Net Income (TTM)
5.88MCNY881.75K · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-12.86%Operating Cash Flow (TTM)
42.62MCNY6.39M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-2.48MCNY-371.13K · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1450CNYUpdated Oct 21, 2026Trailing Annual Dividend Yield
0.50%vs all stocks
5-Year Average Dividend Yield
0.62%vs all stocks
Payout Ratio
186.62%Minority Interest (Equity)
30.51MCNYFY2025 · Dec 31, 2025Revenue
234.84MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
55.74MCNYFY2025 · Dec 31, 2025Gross Profit
179.10MCNYFY2025 · Dec 31, 2025Operating Income
17.14MCNY2.57M · vs all stocks (USD)
Pre-tax Income
21.00MCNYFY2025 · Dec 31, 2025Income Tax Expense
1.10MCNYFY2025 · Dec 31, 2025Net Income
19.90MCNYFY2025 · Dec 31, 2025EBIT
21.44MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
56.78MCNYFY2025 · Dec 31, 2025Research & Development
11.25MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
109.49MCNYFY2025 · Dec 31, 2025Other Operating Expenses
7.54MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
450.02KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
444.83KCNYFY2025 · Dec 31, 2025EPS (Basic)
0.2863CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.2863CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
76.49MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
76.49MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
19.90MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
2.00MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
18.24MCNYFY2025 · Dec 31, 2025Free Cash Flow
-47.82MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
28.95MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
19.90MCNYFY2025 · Dec 31, 2025Other Non-cash Items
523.00KCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
1.25MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-3.43MCNYFY2025 · Dec 31, 2025Capital Expenditures
-66.06MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.08BCNYFY2025 · Dec 31, 2025Sale of Investments
956.78MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-185.64MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
11.53MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-10.00MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-20.32MCNYFY2025 · Dec 31, 2025Other Financing Charges
-5.36MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-24.15MCNYFY2025 · Dec 31, 2025Shares Outstanding
76.49MSharesUpdated Oct 21, 2026Float Shares
41.83MSharesUpdated Oct 21, 2026% Held by Insiders
48.68%vs all stocks
% Held by Institutions
11.56%vs all stocks
Total Cash (MRQ)
223.80MCNY33.55M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.96CNYUpdated Oct 21, 2026Total Debt (MRQ)
39.98MCNY5.99M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0444xCurrent Ratio (MRQ)
3.33xBook Value per Share (MRQ)
11.54CNYUpdated Oct 21, 2026Total Assets
1.06BCNY159.12M · vs all stocks (USD)
Total Current Assets
342.86MCNYFY2025 · Dec 31, 2025Total Liabilities
126.80MCNYFY2025 · Dec 31, 2025Total Non-current Assets
718.72MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
38.38MCNYFY2025 · Dec 31, 2025Total Current Liabilities
88.42MCNYFY2025 · Dec 31, 2025Cash
28.94MCNYFY2025 · Dec 31, 2025Cash Equivalents
565.59KCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
29.51MCNYFY2025 · Dec 31, 2025Other Short-term Investments
206.95MCNYFY2025 · Dec 31, 2025Accounts Receivable
32.92MCNYFY2025 · Dec 31, 2025Inventory
28.19MCNYFY2025 · Dec 31, 2025Accounts Payable
48.84MCNYFY2025 · Dec 31, 2025Short-term Debt
11.61MCNYFY2025 · Dec 31, 2025Other Current Liabilities
390.75KCNYFY2025 · Dec 31, 2025Common Stock (Book)
76.49MCNYFY2025 · Dec 31, 2025Retained Earnings
391.07MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
934.78MCNY140.11M · vs all stocks (USD)
52-Week Low
21.88CNYUpdated Oct 21, 202652-Week High
39.98CNYUpdated Oct 21, 202652-Week Change
-8.16%vs all stocks
Beta
0.5200xvs all stocks
50-Day MA
29.00CNYUpdated Oct 21, 2026200-Day MA
29.15CNYUpdated Oct 21, 2026Avg 10-Day Volume
6.56MSharesUpdated Oct 21, 2026Avg 30-Day Volume
5.96MSharesUpdated Oct 21, 2026Diluted EPS (TTM)
0.0800CNYUpdated Oct 21, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Pays more per share than it earned over the last twelve monthsSignificant
Payout Ratio: 1.87Dividend per Share: 0.14Earnings per Share: 0.08
High gross margins eroded by operating costsNotable
Gross Margin: 0.76Profit Margin: 0.03
Financial Health
Altman Z-Score 11.52: safe zoneNotable
Altman Z-Score: 11.52
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Revenue is $31.17M, lower than 95% of all stocks globallySignificant
Revenue (USD): 31,170,510.451Global P5: 37,231,057.061
Companies that share the same coordination system — how they create, deliver, or capture value.
Jiangsu Canopus Wisdom MedTech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hainan Huluwa Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tuoxin Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
X4 Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Enwei Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Atea Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Capricor Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Newron Pharmaceuticals SpA
Tier 1ProductionApproval-Gated PipelineRuleRisk
Emergent BioSolutions Inc.
Tier 1ProductionApproval-Gated PipelineRule
Grape King Bio Ltd.
Tier 1ProductionApproval-Gated PipelineRule